Lv11
30 积分 2024-06-21 加入
Efficacy and safety of dual-pathway inhibition in patients with cardiovascular disease: a meta-analysis of 49 802 patients from 7 randomized trials
22天前
已完结
Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease
1个月前
已完结
Reduced vs full-dose direct oral anticoagulants for extended treatment of cancer-associated venous thromboembolism: a systematic review and meta-analysis of randomized trials
1个月前
已关闭
Reduced vs full-dose direct oral anticoagulants for extended treatment of cancer-associated venous thromboembolism: a systematic review and meta-analysis of randomized trials
1个月前
已关闭
Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism
1个月前
已完结
Human recombinant activated factor VII for upper gastrointestinal bleeding in patients with liver diseases
2个月前
已完结
Efficacy and safety of bovine activated factors IIa/VIIa/IXa/Xa in patients with active gastrointestinal bleeding: a proof of concept study
3个月前
已完结
A Randomized Control Trial of Thromboelastography-Guided Transfusion in Cirrhosis for High-Risk Invasive Liver-Related Procedures
4个月前
已完结
Effectiveness and safety of apixaban and warfarin in patients with new- onset atrial fibrillation after advanced chronic kidney disease or end-stage kidney disease
6个月前
已完结
皖公网安备34019202002308
